Knockdown of Cdc25B in Renal Cell Carcinoma is Associated with Decreased Malignant Features |
Yu, Xiu-Yue
(Department of Urology, The First Hospital of China Medical University)
Zhang, Zhe (Department of Urology, The First Hospital of China Medical University) Zhang, Guo-Jun (Department of Hematology, Shengjing Hospital of China Medical University) Guo, Kun-Feng (Department of Urology, The First Hospital of China Medical University) Kong, Chui-Ze (Department of Urology, The First Hospital of China Medical University) |
1 | Gabrielli BG, Clark JM, McCormack AK, et al (1997). Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/ Cdk2. J Biol Chem, 272, 28607-14. DOI |
2 | Giles N, Forrest A, Gabrielli B (2003). 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. J Biol Chem, 278, 28580-7. DOI |
3 | Girolami F, Passerini I, Gargano D, et al (2002). Microsatellite analysis of chromosome 3p region in sporadic renal cell carcinomas. Pathol Oncol Res, 8, 241-4. DOI |
4 | Goldstone S, Pavey S, Forrest A, et al (2001). Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene, 20, 921-32. DOI |
5 | Kardas I, Mrozek K, Babinska M, et al (2005). Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol Rep, 13, 949-56. |
6 | Karlsson C, Katich S, Hagting A, et al (1999). Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol, 146, 573-84. DOI |
7 | Kieffer I, Lorenzo C, Dozier C, et al (2007). Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene, 26, 7847-58. DOI |
8 | Lammer C, Wagerer S, Saffrich R, et al (1998). The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci, 111, 2445-53. |
9 | Leroy X, Zini L, Buob D, et al (2007). Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med, 131, 102-6. |
10 | Liffers ST, Munding JB, Vogt M, et al (2011). MicroRNA- 148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest, 91, 1472-9. DOI |
11 | Lindqvist A, Kallstrom H, Karlsson Rosenthal C (2004). Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J Cell Sci, 117, 4979-90. DOI ScienceOn |
12 | Loffler H, Rebacz B, Ho AD, et al (2006). Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events. Cell Cycle, 5, 2543-7. DOI |
13 | van Vugt MA, Bras A, Medema RH (2004). Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell, 15, 799-811. DOI |
14 | Vazquez-Novelle MD, Mailand N, Ovejero S, et al (2010). Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B. J Biol Chem, 285, 40544-53. DOI |
15 | Wang Z, Trope CG, Florenes VA, et al (2010). Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes. BMC Cancer, 10, 233. DOI |
16 | Young AN, Master VA, Paner GP, Wang MD, Amin MB (2008). Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol, 15, 28-38. DOI |
17 | Boutros R, Dozier C, Ducommun B (2006). The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol, 18, 185-91. DOI |
18 | Forrest A, Gabrielli B (2001). Cdc25B activity is regulated by 14-3-3. Oncogene, 20, 4393-401. DOI |
19 | Boutros R, Lobjois V, Ducommun B (2007). CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev, 7, 495-507. DOI |
20 | Gabrielli BG, De Souza CP, Tonks ID, et al (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci, 109, 1081-93. |